Ajanta Pharma Limited (AJANTPHARM.NS)
INR 2876.45
(-0.56%)
INR 2876.45
(-0.56%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 19.67 Billion INR | 56.63% |
| 2022 | 6.61 Billion INR | -18.08% |
| 2021 | 8.07 Billion INR | -9.26% |
| 2020 | 8.9 Billion INR | 51.48% |
| 2019 | 5.87 Billion INR | 18.83% |
| 2018 | 4.94 Billion INR | -18.54% |
| 2017 | 6.07 Billion INR | -9.02% |
| 2016 | 6.67 Billion INR | 23.0% |
| 2015 | 5.42 Billion INR | 19.61% |
| 2014 | 4.53 Billion INR | 39.64% |
| 2013 | 3.24 Billion INR | 70.7% |
| 2012 | 1.9 Billion INR | 65.36% |
| 2011 | 1.15 Billion INR | 54.72% |
| 2010 | 743.87 Million INR | 30.14% |
| 2009 | 571.59 Million INR | 7.11% |
| 2008 | 533.65 Million INR | 18.53% |
| 2007 | 450.23 Million INR | 41.81% |
| 2006 | 317.49 Million INR | 24.28% |
| 2005 | 255.46 Million INR | 30.28% |
| 2004 | 196.08 Million INR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 6.29 Billion INR | 112.43% |
| 2024 Q1 | 2.96 Billion INR | 21.43% |
| 2023 Q1 | 2.48 Billion INR | 61.99% |
| 2023 Q2 | 2.78 Billion INR | 12.15% |
| 2023 FY | 10.36 Billion INR | 56.63% |
| 2023 Q3 | 2.93 Billion INR | 5.43% |
| 2023 Q4 | 2.44 Billion INR | -16.81% |
| 2022 Q1 | 1.89 Billion INR | 5.9% |
| 2022 FY | 6.61 Billion INR | -18.08% |
| 2022 Q4 | 1.53 Billion INR | -10.52% |
| 2022 Q2 | 2.03 Billion INR | 7.37% |
| 2022 Q3 | 1.71 Billion INR | -16.08% |
| 2021 Q2 | 2.31 Billion INR | 22.16% |
| 2021 FY | 8.07 Billion INR | -9.26% |
| 2021 Q1 | 1.89 Billion INR | -20.64% |
| 2021 Q4 | 1.79 Billion INR | -13.69% |
| 2021 Q3 | 2.07 Billion INR | -10.13% |
| 2020 FY | 8.9 Billion INR | 51.48% |
| 2020 Q2 | 2.45 Billion INR | 25.98% |
| 2020 Q3 | 2.12 Billion INR | -13.57% |
| 2020 Q1 | 1.95 Billion INR | 31.75% |
| 2020 Q4 | 2.38 Billion INR | 12.25% |
| 2019 Q4 | 1.48 Billion INR | -8.75% |
| 2019 Q1 | 1.45 Billion INR | 24.4% |
| 2019 FY | 5.87 Billion INR | 18.83% |
| 2019 Q2 | 1.54 Billion INR | 6.07% |
| 2019 Q3 | 1.62 Billion INR | 5.13% |
| 2018 Q2 | 1.48 Billion INR | 5.99% |
| 2018 Q1 | 1.4 Billion INR | 14.18% |
| 2018 FY | 4.94 Billion INR | -18.54% |
| 2018 Q4 | 1.17 Billion INR | 32.04% |
| 2018 Q3 | 886.4 Million INR | -40.4% |
| 2017 Q3 | 1.82 Billion INR | 7.89% |
| 2017 Q2 | 1.69 Billion INR | 48.35% |
| 2017 FY | 6.07 Billion INR | -9.02% |
| 2017 Q1 | 1.14 Billion INR | -19.96% |
| 2017 Q4 | 1.22 Billion INR | -32.67% |
| 2016 Q3 | 1.62 Billion INR | -3.78% |
| 2016 Q4 | 1.42 Billion INR | -12.42% |
| 2016 FY | 6.67 Billion INR | 23.0% |
| 2016 Q2 | 1.69 Billion INR | 10.09% |
| 2016 Q1 | 1.53 Billion INR | 17.83% |
| 2015 FY | 5.42 Billion INR | 19.61% |
| 2015 Q4 | 1.3 Billion INR | -14.31% |
| 2015 Q3 | 1.52 Billion INR | 6.46% |
| 2015 Q2 | 1.42 Billion INR | 27.27% |
| 2015 Q1 | 1.12 Billion INR | -6.39% |
| 2014 Q4 | 1.19 Billion INR | -10.02% |
| 2014 Q3 | 1.33 Billion INR | 14.78% |
| 2014 Q1 | 846.7 Million INR | 0.0% |
| 2014 FY | 4.53 Billion INR | 39.64% |
| 2014 Q2 | 1.16 Billion INR | 37.12% |
| 2013 FY | 3.24 Billion INR | 70.7% |
| 2012 Q4 | - INR | 0.0% |
| 2012 FY | 1.9 Billion INR | 65.36% |
| 2012 Q1 | - INR | 0.0% |
| 2012 Q2 | - INR | 0.0% |
| 2012 Q3 | - INR | 0.0% |
| 2011 FY | 1.15 Billion INR | 54.72% |
| 2010 FY | 743.87 Million INR | 30.14% |
| 2009 FY | 571.59 Million INR | 7.11% |
| 2008 FY | 533.65 Million INR | 18.53% |
| 2007 FY | 450.23 Million INR | 41.81% |
| 2006 FY | 317.49 Million INR | 24.28% |
| 2005 FY | 255.46 Million INR | 30.28% |
| 2004 FY | 196.08 Million INR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Sigachi Industries Limited | 1.47 Billion INR | -1235.053% |
| Ind-Swift Limited | 1.22 Billion INR | -1505.047% |
| Bajaj HealthCare Limited | - INR | -Infinity% |
| Sakar Healthcare Limited | 495.5 Million INR | -3871.153% |
| Aurobindo Pharma Limited | 104.5 Billion INR | 81.171% |
| Innova Captab Limited | 2.53 Billion INR | -676.712% |
| Divi's Laboratories Limited | 18.31 Billion INR | -7.468% |
| AstraZeneca Pharma India Limited | 4.47 Billion INR | -339.824% |
| Morepen Laboratories Limited | 4.17 Billion INR | -371.445% |
| Mankind Pharma Limited | 40.86 Billion INR | 51.851% |
| Sequent Scientific Limited | - INR | -Infinity% |
| Wanbury Limited | 1.7 Billion INR | -1052.602% |
| Laurus Labs Limited | 3.94 Billion INR | -398.336% |
| Nectar Lifesciences Limited | 3.89 Billion INR | -405.766% |
| Glenmark Life Sciences Limited | 8.97 Billion INR | -119.143% |
| Alembic Limited | 767.77 Million INR | -2462.916% |
| Hikal Limited | 1.49 Billion INR | -1216.912% |
| Alembic Pharmaceuticals Limited | 5.75 Billion INR | -241.733% |
| Neuland Laboratories Limited | 5.31 Billion INR | -270.007% |
| J. B. Chemicals & Pharmaceuticals Limited | 7.54 Billion INR | -160.915% |
| Glenmark Pharmaceuticals Limited | 6.5 Billion INR | -202.617% |
| IOL Chemicals and Pharmaceuticals Limited | 4.94 Billion INR | -298.149% |
| Themis Medicare Limited | 1.3 Billion INR | -1410.032% |
| RPG Life Sciences Limited | 2.29 Billion INR | -758.409% |
| Zydus Lifesciences Limited | 45.39 Billion INR | 56.65% |
| Lupin Limited | 27.75 Billion INR | 29.112% |
| Amrutanjan Health Care Limited | 621.02 Million INR | -3068.51% |
| Wockhardt Limited | 140 Million INR | -13955.214% |
| Vaishali Pharma Limited | 6.29 Million INR | -312535.844% |
| Aarti Pharmalabs Limited | 3.12 Billion INR | -529.046% |
| Jagsonpal Pharmaceuticals Limited | 214.04 Million INR | -9093.282% |
| Jubilant Pharmova Limited | 5.18 Billion INR | -279.212% |
| FDC Limited | 3.03 Billion INR | -548.615% |
| Dr. Reddy's Laboratories Limited | 67.72 Billion INR | 70.947% |
| Kilitch Drugs (India) Limited | 208.05 Million INR | -9357.967% |
| Eris Lifesciences Limited | 5.18 Billion INR | -279.745% |
| Venus Remedies Limited | 534.65 Million INR | -3580.401% |
| ZIM Laboratories Limited | 1.09 Billion INR | -1691.919% |
| Bliss GVS Pharma Limited | 1.23 Billion INR | -1498.48% |
| Par Drugs and Chemicals Limited | 551.58 Million INR | -3467.385% |
| Caplin Point Laboratories Limited | 7.22 Billion INR | -172.339% |
| Shilpa Medicare Limited | 3.76 Billion INR | -423.114% |
| Albert David Limited | 1.33 Billion INR | -1374.555% |
| Hester Biosciences Limited | 364.77 Million INR | -5294.44% |
| Suven Pharmaceuticals Limited | 4.6 Billion INR | -327.058% |
| Solara Active Pharma Sciences Limited | -3.85 Billion INR | 610.714% |
| Gufic Biosciences Limited | 2.89 Billion INR | -579.98% |
| Windlas Biotech Limited | 1.29 Billion INR | -1414.932% |
| Procter & Gamble Health Limited | 2.78 Billion INR | -606.292% |
| Aarey Drugs & Pharmaceuticals Limited | 2.83 Million INR | -695008.071% |
| Mangalam Drugs & Organics Limited | 27.45 Million INR | -71563.268% |
| Granules India Limited | 6.52 Billion INR | -201.417% |
| Aarti Drugs Limited | 7.14 Billion INR | -175.256% |
| Bal Pharma Limited | 214.56 Million INR | -9070.616% |
| Alkem Laboratories Limited | 19.46 Billion INR | -1.107% |
| Sun Pharmaceutical Industries Limited | 104.3 Billion INR | 81.135% |
| Lincoln Pharmaceuticals Limited | 1.9 Billion INR | -932.21% |
| Medicamen Biotech Limited | - INR | -Infinity% |
| Unichem Laboratories Limited | - INR | -Infinity% |
| Bafna Pharmaceuticals Limited | 237.66 Million INR | -8179.566% |
| Biofil Chemicals and Pharmaceuticals Limited | 20.65 Million INR | -95161.909% |
| Valiant Laboratories Limited | - INR | -Infinity% |
| Orchid Pharma Limited | 2.36 Billion INR | -733.403% |
| Medico Remedies Limited | 277.11 Million INR | -7000.694% |
| Ind-Swift Laboratories Limited | 2 Billion INR | -879.441% |
| Ipca Laboratories Limited | 29.59 Billion INR | 33.515% |
| Brooks Laboratories Limited | -72.25 Million INR | 27334.263% |
| Syncom Formulations (India) Limited | 249.25 Million INR | -7794.572% |
| Piramal Enterprises Limited | - INR | -Infinity% |
| Torrent Pharmaceuticals Limited | 25.33 Billion INR | 22.332% |
| NATCO Pharma Limited | 25.96 Billion INR | 24.207% |
| Suven Life Sciences Limited | -1.22 Billion INR | 1705.233% |
| Krebs Biochemicals & Industries Limited | - INR | -Infinity% |
| Strides Pharma Science Limited | 5.22 Billion INR | -276.541% |
| Indoco Remedies Limited | 1.52 Billion INR | -1190.823% |
| Alpa Laboratories Limited | 61.51 Million INR | -31887.808% |
| Lasa Supergenerics Limited | -458 Million INR | 4396.307% |
| Sun Pharma Advanced Research Company Limited | -4.11 Billion INR | 578.18% |